BioFactura Funded $16 Million Contract Option for its Smallpox Biodefense Therapeutic
Frederick, Maryland, October 2, 2023: BioFactura, Inc. today announced a contract option activation of over $16 million by the Biomedical Advanced Research and Development Authority (BARDA) part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, as part of its prime contract valued at over $77 million … Continue reading